跳至主要内容
临床试验/NCT05996653
NCT05996653招募中不适用

A Multi-institutional Observational Study of CEST Imaging in Low-grade Glioma

Sunnybrook Health Sciences Centre4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年8月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
4
主要终点
The time-to-progression as measured by Saturation Transfer (ST)-MRI (based on a change in volume or parameter value of over 10%) relative to the time-to-progression as measured by standard MRI using RANO-LGG.

研究概览

简要总结

Low grade gliomas (LGGs) are malignant, infiltrative and incurable brain tumours that typically present in the younger population. This project proposes to use non-contrast metabolic "Saturation Transfer" (ST)-MRI to evaluate LGG tumour progression and aims to predict early changes in LGG. Early identification of LGG patients whose tumours will progress will permit early interventions. ST-MRI does not involve any intravenous injection of contrast and which acquires metabolic information not seen by standard MRI.

详细描述

Please see trial details below:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be at least 12 years of age;
  • Diagnosed with:
  • Cohort A (pre-surgical): Suspected LGG (oligodendroglioma or astrocytoma), based on any combination of histological, molecular, radiological, and/or clinical findings; or
  • Cohort B (post-surgical): IDH1/2-mutant or IDH-wildtype (WT) low-grade glioma candidate for observation
  • No contraindications to MRI;
  • eGFR > 30 ml/min;
  • No prior chemotherapy or radiation therapy;
  • No need for upfront treatment (surgery, chemotherapy, and/or radiation therapy)
  • Followed at either Sunnybrook Health Sciences Centre or at St Michael's Hospital

排除标准

  • Need for upfront post-surgical treatment with either chemotherapy and/or radiation therapy

结局指标

主要结局

The time-to-progression as measured by Saturation Transfer (ST)-MRI (based on a change in volume or parameter value of over 10%) relative to the time-to-progression as measured by standard MRI using RANO-LGG.

时间窗: Up to 6 years, from date of initial (ST)-MRI scan until the date of progression

Time-to-progression refers to clinical progression of a low-grade glioma to a higher tumour grade.

次要结局

  • Accuracy of Saturation Transfer (ST)-MRI for detecting progression (based on a change in volume or parameter value of over 10%).(Up to 6 years, from date of initial (ST)-MRI scan until the date of progression)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. MaryJane Lim Fat

Principal Investigator

Sunnybrook Health Sciences Centre

研究点 (4)

Loading locations...

相似试验